[EN] POLYMORPHIC AND PSEUDOPOLYMORPHIC FORMS OF A PHARMACEUTICAL COMPOUND<br/>[FR] FORMES POLYMORPHES ET PSEUDOPOLYMORPHES D'UN COMPOSÉ PHARMACEUTIQUE
申请人:NOVEXEL SA
公开号:WO2011042560A1
公开(公告)日:2011-04-14
The invention relates to the sodium salt of (1R,2S,5R)-7-oxo-6-sulfooxy-1,6- diazabicyclo[3.2.1]octane-2-carboxamide in hydrated or anhydrous crystallized enantiomeric form and in particular in the novel crystallized polymorphic and pseudopolymorphic forms "A", "B", "D" and "E" defined in the application, as well as the method of preparation. The compound of the invention can be used as a medicament, in particular a beta-lactamase inhibitor.
本发明涉及(1R,2S,5R)-7-氧代-6-磺酸基氧代-1,6-二氮杂双环[3.2.1]辛烷-2-羧酰胺的钠盐,其以水合或无水结晶对映体形式存在,特别是在本申请中定义的新的结晶多态和伪多态形式“A”、“B”、“D”和“E”中,以及其制备方法。本发明的化合物可以用作药物,特别是β-内酰胺酶抑制剂。